Merck Off The Hook In Fosamax Fracture Suit, Judge Rules

By Jeff Sistrunk ( June 27, 2013, 9:34 PM EDT) -- A New Jersey federal judge on Thursday said claims that Merck & Co. failed to warn a consumer of the possible risk of femur fractures from the use of its bone drug Fosamax are preempted under federal law because the U.S. Food and Drug Administration refused to strengthen the drug's label the year the consumer was injured....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!